The loss of IAP expression during HL-60 cell differentiation is caspase-independent. 2002

B T Doyle, and A J O'Neill, and P Newsholme, and J M Fitzpatrick, and R W G Watson
Department of Surgery, Mater Misericordiae Hospital, University College Dublin, Ireland.

Human promyelocytic leukaemia cells (HL-60) differentiate into neutrophil-like cells that die spontaneously by apoptosis when treated with retinoic acid (RA). Inhibitors of apoptosis proteins (IAP) bind to and inhibit caspases 3, 7, and 9 activity and the induction of apoptosis. In this study, we demonstrate that undifferentiated HL-60 cells express IAP. During their differentiation, IAP expression is decreased at the mRNA and protein levels. In addition, we show that there is a corresponding increase in the expression and functional activity of active caspases 3 and 9. This activity was associated with the cleavage of XIAP, NAIP, and cIAP-2. Most importantly, we demonstrate that blocking caspase activity does not alter the decrease in IAP protein expression during differentiation but prevents caspase activation, IAP cleavage, and the induction of apoptosis. This result shows that the loss of IAP expression is independent of the induction of apoptosis and is solely related to the differentiation process. However, IAP cleavage is caspase-dependent. Terminal differentiation results in an altered apoptotic phenotype that is associated with the induction of HL-60 cell apoptosis.

UI MeSH Term Description Entries
D009419 Nerve Tissue Proteins Proteins, Nerve Tissue,Tissue Proteins, Nerve
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014176 Protein Biosynthesis The biosynthesis of PEPTIDES and PROTEINS on RIBOSOMES, directed by MESSENGER RNA, via TRANSFER RNA that is charged with standard proteinogenic AMINO ACIDS. Genetic Translation,Peptide Biosynthesis, Ribosomal,Protein Translation,Translation, Genetic,Protein Biosynthesis, Ribosomal,Protein Synthesis, Ribosomal,Ribosomal Peptide Biosynthesis,mRNA Translation,Biosynthesis, Protein,Biosynthesis, Ribosomal Peptide,Biosynthesis, Ribosomal Protein,Genetic Translations,Ribosomal Protein Biosynthesis,Ribosomal Protein Synthesis,Synthesis, Ribosomal Protein,Translation, Protein,Translation, mRNA,mRNA Translations
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D051034 Inhibitor of Apoptosis Proteins A conserved class of proteins that control APOPTOSIS in both VERTEBRATES and INVERTEBRATES. IAP proteins interact with and inhibit CASPASES, and they function as ANTI-APOPTOTIC PROTEINS. The protein class is defined by an approximately 80-amino acid motif called the baculoviral inhibitor of apoptosis repeat; some members have ubiquitin-protein ligase activity. BIRC2 Protein,Baculoviral IAP Repeat Containing Protein 2,Baculoviral IAP Repeat-Containing 2 Protein,Baculoviral Inhibitor Of Apoptosis Repeat Proteins,Cellular Inhibitor of Apoptosis 1 Protein,IAP Protein (Apoptosis),IAP Repeat Containing Proteins,IAP2 Protein,Inhibitor of Apoptosis 2 Protein,Inhibitor-Of-Apoptosis Protein,c-IAP1 Protein,cIAP1 Protein,Apoptosis Proteins Inhibitor,Baculoviral IAP Repeat Containing 2 Protein,Inhibitor Of Apoptosis Protein
D051616 Neuronal Apoptosis-Inhibitory Protein An inhibitor of apoptosis protein that was initially identified during analysis of CHROMOSOME DELETIONS associated with SPINAL MUSCULAR ATROPHY. Naip contains a nucleotide binding oligomerization domain and a carboxy-terminal LEUCINE rich repeat. NAIP Protein,Apoptosis-Inhibitory Protein, Neuronal,Neuronal Apoptosis Inhibitory Protein
D051636 X-Linked Inhibitor of Apoptosis Protein An inhibitor of apoptosis protein that is translated by a rare cap-independent mechanism. It blocks caspase-mediated cellular destruction by inhibiting CASPASE 3; CASPASE 7; and CASPASE 9. X-Linked IAP Protein,XIAP Protein,IAP Protein, X-Linked,X Linked IAP Protein,X Linked Inhibitor of Apoptosis Protein

Related Publications

B T Doyle, and A J O'Neill, and P Newsholme, and J M Fitzpatrick, and R W G Watson
January 1994, Journal of immunology (Baltimore, Md. : 1950),
B T Doyle, and A J O'Neill, and P Newsholme, and J M Fitzpatrick, and R W G Watson
July 1997, Archives of biochemistry and biophysics,
B T Doyle, and A J O'Neill, and P Newsholme, and J M Fitzpatrick, and R W G Watson
April 1995, Annals of the New York Academy of Sciences,
B T Doyle, and A J O'Neill, and P Newsholme, and J M Fitzpatrick, and R W G Watson
November 1988, Cancer research,
B T Doyle, and A J O'Neill, and P Newsholme, and J M Fitzpatrick, and R W G Watson
January 2007, In vitro cellular & developmental biology. Animal,
B T Doyle, and A J O'Neill, and P Newsholme, and J M Fitzpatrick, and R W G Watson
December 1991, Biochemical and biophysical research communications,
B T Doyle, and A J O'Neill, and P Newsholme, and J M Fitzpatrick, and R W G Watson
January 2012, Asian Pacific journal of cancer prevention : APJCP,
B T Doyle, and A J O'Neill, and P Newsholme, and J M Fitzpatrick, and R W G Watson
September 1994, Biochemical and biophysical research communications,
B T Doyle, and A J O'Neill, and P Newsholme, and J M Fitzpatrick, and R W G Watson
January 2018, PloS one,
B T Doyle, and A J O'Neill, and P Newsholme, and J M Fitzpatrick, and R W G Watson
August 1987, Nucleic acids research,
Copied contents to your clipboard!